BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 686527)

  • 21. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):649-57. PubMed ID: 7029149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survival rate of 2636 patients with bronchogenic carcinoma].
    Liao ML
    Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):34-7. PubMed ID: 2843332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery, BCG immunotherapy, and multichemotherapy in T3 stage-3 bronchogenic carcinoma.
    Rioseco A
    Chest; 1981 Feb; 79(2):176-85. PubMed ID: 7460649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
    Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
    Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchogenic carcinoma: the true story.
    Sullivan HJ
    Geriatrics; 1973 Mar; 28(3):140-2. PubMed ID: 4348026
    [No Abstract]   [Full Text] [Related]  

  • 26. Bronchogenic carcinoma in patients age 30 and younger.
    Whooley BP; Urschel JD; Antkowiak JG; Takita H
    Ann Thorac Cardiovasc Surg; 2000 Apr; 6(2):86-8. PubMed ID: 10870000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bronchial cancer from the viewpoint of 2 neighboring regional cancer registers].
    Enderlin F; Breitfellner G; Gloor F; Parschalk K
    Wien Med Wochenschr; 1986 May; 136(9):203-7. PubMed ID: 3017013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bronchial carcinoma in subjects under 40].
    Ardissone F; Rapellino M; Obert R; Baldi S; Scappaticci E; Pecchio F; Borasio P
    Minerva Med; 1989 Dec; 80(12):1301-4. PubMed ID: 2560151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of bronchial cancer with a water-saline extract of BCG].
    Khadzhiev S; Kavaklieva-Dimitrova Ia
    Vopr Onkol; 1971; 17(8):51-7. PubMed ID: 4943964
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the results of radiotherapy in planocellular bronchial carcinoma].
    Nagorni-Obradović L
    Plucne Bolesti; 1991; 43(1-2):26-9. PubMed ID: 1766981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunorestoration in epidermoid cancer of the bronchi. Therapeutic results (proceedings)].
    Pouillart P; Palangie T; Jouve M; Huguenin P; Gautier H; Morin P; Baron A
    J Radiol Electrol Med Nucl; 1978 Nov; 59(11):654-7. PubMed ID: 748546
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinoma.
    Rowland KM; Bonomi P; Taylor SG; Maffey S; Reddy S; Lee MS
    NCI Monogr; 1988; (6):323-5. PubMed ID: 2832766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
    Wagner W; von Eiff M; Klinke F; Micke O; Rübe C; Willich N
    Strahlenther Onkol; 1995 Jul; 171(7):390-7. PubMed ID: 7631260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple primary malignant tumors of the larynx and lung].
    Croce A; Neri G; Moretti A; Bianchedi M
    G Chir; 1993 Sep; 14(7):354-8. PubMed ID: 8286179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical presentation and management of patients with carcinoma of the lung: a 14-year experience.
    Kirsh MM; Tashian J; Sloan H
    J Fam Pract; 1979 Jun; 8(6):1127-31. PubMed ID: 448296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
    Jansen HM; The TH; Orie NG
    Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial.
    Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS
    Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 40. Conservative treatment of bronchogenic carcinoma.
    Rohwedder JJ
    Compr Ther; 1979 Oct; 5(10):66-73. PubMed ID: 227641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.